Brief: Sutro Biopharma Presents Preclinical Data For Its Ror1 Targeting Antibody Drug Conjugate Stro-003 At Aacr Annual Meeting 2023
18/04/2023 20:55
April 18 (Reuters) - Sutro Biopharma Inc STRO.O :
* SUTRO BIOPHARMA PRESENTS PRECLINICAL DATA FOR ITS ROR1
TARGETING
ANTIBODY DRUG CONJUGATE STRO-003 AT AACR ANNUAL MEETING 2023
* SUTRO BIOPHARMA INC - CURRENTLY PREPARING FOR IND-ENABLING
STUDIES OF STRO-003, WHICH IT ANTICIPATES COMPLETING IN Q1 OF
2024
Source text for Eikon: ID:nGNX7bJYmt
Further company coverage: STRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates